Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway

被引:0
|
作者
Marta Szybowska
Ozgur Mete
Evan Weber
Josh Silver
Raymond H. Kim
机构
[1] University Health Network,Fred A. Litwin Family Center in Genetic Medicine
[2] University Health Network,Department of Laboratory Medicine and Pathobiology
[3] University of Toronto,Medical Genetics
[4] McGill University Health Centre,Department of Molecular Genetics
[5] University of Toronto,Division of Medical Oncology, Department of Medicine
[6] University of Toronto,Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Fred. A. Litwin Centre in Genetic Medicine
[7] University Health Network,undefined
[8] University of Toronto,undefined
来源
Endocrine Pathology | 2019年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neuroendocrine neoplasms (NENs) have been primarily associated with germline pathogenic variants in genes involved in chromatin remodeling (MEN1), cell cycle control (CDKN1B), PI3K/mTOR signaling (TSC1/2, PTEN) as well as pseudohypoxia (VHL, SDHx). Recent work has implicated various genes involved in DNA repair pathways in the pathophysiology of a subset of pancreatic neuroendocrine neoplasms, including BRCA2, via the homologous recombination pathway (HRD). To date, germline variants in other HRD pathway genes have not been described to contribute to NEN. PALB2, RAD51C, and BARD1 are additional tumor suppressor genes which also mediate repair of double stranded DNA breaks through the HRD pathway and are implicated in hereditary breast (PALB2; BARD1) and ovarian (RAD51C) cancer. Here we report three cases of NEN associated with germline pathogenic variants in PALB2 (pancreatic NEN), RAD51C (thymic NEN), and BARD1 (pancreaticoduodenal NEN) respectively, further linking the DNA repair pathway to NENs.
引用
收藏
页码:237 / 245
页数:8
相关论文
共 50 条
  • [21] Germline pathogenic variants associated with ovarian cancer: A historical overview
    Johansen, Emma Lund
    Thusgaard, Christine Fribert
    Thomassen, Mads
    Boonen, Susanne Eriksen
    Jochumsen, Kirsten Marie
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 44
  • [22] Are pathogenic germline variants in metastatic melanoma associated with unfavorable survival?
    Biskup, S.
    Amaral, T.
    Sinnberg, T.
    Nieser, M.
    Martus, P.
    Garbe, C.
    Battke, F.
    Forschner, A.
    Schulze, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 91 - 91
  • [23] LODESTAR: A Single Arm Phase II Study of Rucaparib in Solid Tumors with Pathogenic Germline or Somatic Variants in Homologous Recombination Repair (HRR) Genes
    Anbil, Sriram
    Seewald, Nicholas J.
    Lin, Kevin
    Craib, Marcia
    Connor, Christy
    Giordano, Heidi
    McLachlan, Karen
    Kwan, Tanya
    Maloney, Lara
    Tukachinsky, Hanna
    Schrock, Alexa
    Wang, Shuoguo
    Sokol, Ethan
    Decker, Brennan
    Nathanson, Katherine
    Domchek, Susan
    Reiss, Kim
    CANCER RESEARCH, 2024, 84 (17)
  • [24] Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing
    Rezqallah, Alejandra
    Torres-Esquius, Sara
    Llop-Guevara, Alba
    Cruellas, Mara
    Martinez, Maria T.
    Romey, Marcel
    Denkert, Carsten
    Serra, Violeta
    Chirivella, Isabel
    Balmana, Judith
    JCO PRECISION ONCOLOGY, 2024, 8
  • [25] Pathogenic Germline Mutations of Homologous Recombination Deficiency (HRD) Genes in Chinese Lung Cancer Patients
    Wang, M.
    Li, S.
    Xue, X.
    Wei, X.
    Ye, Z.
    Su, Y.
    Li, L.
    Xu, Z.
    Guo, T.
    Xie, J.
    Wang, W.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S534 - S534
  • [26] Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?
    Amaral, Teresa
    Schulze, Martin
    Sinnberg, Tobias
    Nieser, Maike
    Martus, Peter
    Battke, Florian
    Garbe, Claus
    Biskup, Saskia
    Forschner, Andrea
    CANCERS, 2020, 12 (05)
  • [27] Homologous Recombination in Rat Germline Stem Cells
    Kanatsu-Shinohara, Mito
    Kato-Itoh, Megumi
    Ikawa, Masahito
    Takehashi, Masanori
    Sanbo, Makoto
    Morioka, Yuka
    Tanaka, Takashi
    Morimoto, Hiroko
    Hirabayashi, Masumi
    Shinohara, Takashi
    BIOLOGY OF REPRODUCTION, 2011, 85 (01) : 208 - 217
  • [28] Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs)
    Perez, Kimberly
    Kulke, Matthew H.
    Chittenden, Anu
    Ukaegbu, Chinedu
    Astone, Kristina
    Alexander, Holly
    Brais, Lauren
    Zhang, Jinming
    Garcia, John
    Esplin, Edward D.
    Yang, Shan
    Da Silva, Annacarolina
    Nowak, Jonathan A.
    Yurgelun, Matthew B.
    Garber, Judy
    Syngal, Sapna
    Chan, Jennifer
    JCO PRECISION ONCOLOGY, 2021, 5 : 808 - 816
  • [29] Germline pathogenic variants in prostate cancer
    Shakroo, Yousif M.
    Seabury Jr, Charles A.
    Iczkowski, Kenneth A.
    Nelson, Kinloch
    Qian, Junqi
    Ramnani, Dharam M.
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 264
  • [30] Pathogenic Germline Variants in Multiple Myeloma
    Thibaud, Santiago
    Etra, Aaron
    Subaran, Ryan
    Soens, Zachry
    Newman, Scott
    Chen, Rong
    Chari, Ajai
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Melnekoff, David T.
    Richard, Shambavi
    Richter, Joshua
    Sanchez, Larysa
    Huang, Kuan-lin
    Lagana, Alessandro
    Parekh, Samir
    Onel, Kenan
    BLOOD, 2021, 138